UBS Group »

Marker Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Marker Therapeutics

Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024020k40k05k10k15k20k
Value ($)Share countHistorical MRKR position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $54k 19k 2.82
2024-03-31 $1.8k 427 4.30
2023-09-30 $421 93 4.54
2023-06-30 $4.7k 1.5k 3.10
2023-03-31 $4.0k 5.6k 0.71